Last reviewed · How we verify
C7R.CD30.CAR-EBVST cells
At a glance
| Generic name | C7R.CD30.CAR-EBVST cells |
|---|---|
| Also known as | Allogeneic CR7.CD30 Chimeric Antigen Receptor Epstein-Barr Virus-Specific T Lymphocytes |
| Sponsor | Baylor College of Medicine |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- C7R.CD30.CAR-EBVST cells CI brief — competitive landscape report
- C7R.CD30.CAR-EBVST cells updates RSS · CI watch RSS
- Baylor College of Medicine portfolio CI